Profiling targetable immune checkpoints in osteosarcoma

Osteosarcomas are aggressive bone tumors for which therapeutic advances have not improved over several decades. Unlike most pediatric tumors, the osteosarcoma genome is remarkably unstable, characterized by numerous copy number alterations and chromosomal structural aberrations. In this study, we as...

Full description

Bibliographic Details
Main Authors: Troy A McEachron, Timothy J Triche, Laurie Sorenson, David M Parham, John D Carpten
Format: Article
Language:English
Published: Taylor & Francis Group 2018-12-01
Series:OncoImmunology
Subjects:
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1475873